Hyperimmunoglobulin D syndrome in childhood
- PMID: 20425018
- DOI: 10.1007/s11926-010-0086-1
Hyperimmunoglobulin D syndrome in childhood
Abstract
Hyperimmunoglobulinemia D and periodic fever syndrome, an autoinflammatory syndrome, is caused by mutations in the gene coding for mevalonate kinase. The disease is clinically characterized by recurrent attacks of fever accompanied by an array of inflammatory symptoms including lymphadenopathy, rash, arthritis, and gastrointestinal complaints. Most patients have their first attack in the first year of life, typically after a childhood vaccination. The frequency of attacks is highest during childhood, with a gradual decrease after adolescence. Frequent fever attacks impair quality of life and the achievement of educational milestones. Recent reports show promising results with anakinra and etanercept to treat the attacks.
Similar articles
-
Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra.Pediatr Rheumatol Online J. 2016 Mar 25;14(1):19. doi: 10.1186/s12969-016-0081-9. Pediatr Rheumatol Online J. 2016. PMID: 27012807 Free PMC article. Review.
-
Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome.J Clin Rheumatol. 2014 Mar;20(2):103-5. doi: 10.1097/01.RHU.0000442576.41537.de. J Clin Rheumatol. 2014. PMID: 24561416
-
Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature.Clin Rheumatol. 2014 Nov;33(11):1681-4. doi: 10.1007/s10067-014-2523-4. Epub 2014 Feb 15. Clin Rheumatol. 2014. PMID: 24531849 Review.
-
Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.Rheumatol Int. 2012 Jan;32(1):249-51. doi: 10.1007/s00296-009-1322-8. Epub 2009 Dec 18. Rheumatol Int. 2012. PMID: 20020131
-
Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.Medicine (Baltimore). 2008 Nov;87(6):301-310. doi: 10.1097/MD.0b013e318190cfb7. Medicine (Baltimore). 2008. PMID: 19011501
Cited by
-
Recent Insights in Pyrin Inflammasome Activation: Identifying Potential Novel Therapeutic Approaches in Pyrin-Associated Autoinflammatory Syndromes.J Clin Immunol. 2023 Dec 22;44(1):8. doi: 10.1007/s10875-023-01621-5. J Clin Immunol. 2023. PMID: 38129719 Review.
-
A Critical Review on the Standardization and Quality Assessment of Nonfunctional Laboratory Tests Frequently Used to Identify Inborn Errors of Immunity.Front Immunol. 2021 Nov 9;12:721289. doi: 10.3389/fimmu.2021.721289. eCollection 2021. Front Immunol. 2021. PMID: 34858394 Free PMC article. Review.
-
Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report.Pediatr Rheumatol Online J. 2021 Nov 22;19(1):161. doi: 10.1186/s12969-021-00645-8. Pediatr Rheumatol Online J. 2021. PMID: 34809655 Free PMC article.
-
Mevalonate Kinase-Associated Diseases: Hunting for Phenotype-Genotype Correlation.J Clin Med. 2021 Apr 7;10(8):1552. doi: 10.3390/jcm10081552. J Clin Med. 2021. PMID: 33917151 Free PMC article.
-
A case report of mevalonate kinase deficiency in a 14-month-old female with fevers and lower extremity weakness.BMC Pediatr. 2019 Jul 20;19(1):245. doi: 10.1186/s12887-019-1617-1. BMC Pediatr. 2019. PMID: 31325964 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical